Microarray Technology is a powerful tool used in molecular biology and genomics for high-throughput analysis of gene expression, DNA sequence variation, protein binding, and other molecular interactions. It enables researchers to simultaneously interrogate thousands to millions of nucleic acid or protein targets on a solid surface, facilitating large-scale studies of gene expression patterns, genetic variants, and protein interactions. The basic principle of microarray technology involves the immobilization of nucleic acid or protein probes, such as DNA oligonucleotides, cDNA fragments, or antibodies, onto a solid support, such as a glass slide or a silicon chip. Target molecules, such as DNA fragments, RNA transcripts, or proteins, are then labelled with fluorescent dyes, radioisotopes, or other detection tags and hybridized to the immobilized probes. Microarrays can be used for various applications, including gene expression profiling, SNP genotyping, comparative genomic hybridization (CGH), chromatin immunoprecipitation (ChIP), and protein-protein interaction studies. In gene expression profiling, microarrays enable researchers to measure the expression levels of thousands of genes simultaneously in a single experiment, providing insights into gene regulatory networks, biological pathways, and disease mechanisms.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy